605116 Aurisco Pharmaceutical
- 24.08
- +1.81+8.13%
Aurisco Pharmaceutical News
Orient: Announcement of Orient Pharmaceutical Co., Ltd. on the completion of the registration of commercial changes and the issuance of business licenses by its wholly-owned subsidiary
Announcement of Orient Pharmaceutical Co., Ltd. on the completion of the registration of industrial and commercial changes and the issuance of business licenses by its wholly-owned subsidiary
Announcement of Orient Pharmaceutical Co., Ltd. on adjusting the amount of entrusted financial management of idle own funds
Announcement of Orient Pharmaceutical Co., Ltd. on using part of the capital raised to increase capital and provide loans to wholly-owned subsidiaries to implement fund-raising projects
Aurisco Pharmaceutical Co., Ltd. issued a public announcement of convertible corporate bonds to unspecified entities for listing.
Aurisco Pharmaceutical Co., Ltd. announced the results of the issuance of convertible corporate bonds to unspecified persons.
Aurisco Pharmaceutical: Aurisco Pharmaceutical Co., Ltd.'s online lottery results announcement for the issuance of convertible corporate bonds to unspecified object
Aurisco Pharmaceutical Co., Ltd.'s online lottery results announcement for the issuance of convertible corporate bonds to unspecified object
Aurisco Pharmaceutical Co., Ltd. announces the online lottery rate and preferential allocation results of the convertible corporate bonds issued to non-specific objects.
Aurisco Pharmaceutical Co., Ltd. issued a convertible corporate bond to unspecified parties. Issuance notice.
Aurisco Pharmaceutical Co., Ltd. announced the online roadshow for the issuance of convertible corporate bonds to unspecified objects.
Credit rating report for aurisco pharmaceutical's convertible corporate bonds issued to unspecified parties in 2024.
Aurisco Pharmaceutical Co., Ltd. announcement for online roadshow of convertible corporate bonds issued to unspecified investors.
Aurisco Pharmaceutical Co., Ltd. issued a summary of convertible corporate bond prospectus to unspecified targets.
Aurisco Pharmaceutical Co., Ltd.'s prospectus for the issuance of convertible corporate bonds to unspecified parties.
Aurisco Pharmaceutical Co., Ltd. issued a convertible corporate bond to unspecified parties.
Announcement of Aurisco Pharmaceutical's wholly-owned subsidiary completing business registration change and issuing new business license.
Aurisco Pharmaceutical Co., Ltd. announced that its application to issue convertible corporate bonds to unspecified objects has been approved and registered by the China Securities Regulatory Commission.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Orient Pharmaceutical Co., Ltd.
Legal Opinion of Guohao Law Firm (Hangzhou) on the 2023 Annual General Meeting of Shareholders of Orient Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
No Data